MedPath
HSA Approval

LAVUDIN STANDARD F.C. TABLET 100 mg

SIN15204P

LAVUDIN STANDARD F.C. TABLET 100 mg

LAVUDIN STANDARD F.C. TABLET 100 mg

March 31, 2017

NOVEM HEALTHCARE PTE LTD

NOVEM HEALTHCARE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM HEALTHCARE PTE LTD
Licence HolderNOVEM HEALTHCARE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AF05

lamivudine

Manufacturer Information

NOVEM HEALTHCARE PTE LTD

Standard Chem. & Pharm. Co. Ltd

Active Ingredients

Lamivudine

100 mg

Lamivudine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LAVUDIN STANDARD F.C. TABLET 100 mg - HSA Approval | MedPath